Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock

被引:13
|
作者
Maybauer, Marc O. [1 ,2 ,3 ,4 ,5 ]
Maybauer, Dirk M. [1 ,2 ,3 ]
Fraser, John F. [4 ,5 ]
Szabo, Csaba [1 ,2 ]
Westphal, Martin [1 ,2 ]
Kiss, Levente [6 ]
Horvath, Eszter M. [6 ]
Nakano, Yoshimitsu [1 ,2 ]
Herndon, David N. [7 ,8 ]
Traber, Lillian D. [1 ,2 ]
Traber, Daniel L. [1 ,2 ]
机构
[1] Univ Texas Med Branch, Dept Anesthesiol, Invest Intens Care Unit, Galveston, TX 77555 USA
[2] Shriners Burns Hosp Children, Galveston, TX 77555 USA
[3] Univ Marburg, Dept Anaesthesiol & Intens Care, D-35033 Marburg, Germany
[4] Prince Charles Hosp Brisbane, Chermside, Qld 4032, Australia
[5] Univ Queensland, Crit Care Res Grp, Chermside, Qld 4032, Australia
[6] Semmelweis Univ, Inst Human Physiol & Clin Expt, H-1094 Budapest, Hungary
[7] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA
[8] Shriners Burns Hosp Children, Galveston, TX 77550 USA
基金
美国国家卫生研究院;
关键词
SMOKE-INHALATION INJURY; MICROVASCULAR BLOOD-FLOW; SEVERE SEPSIS; PEROXYNITRITE; HYPOTENSION; IMPROVES; MODEL; HEMODYNAMICS; VENTILATION; INHIBITION;
D O I
10.1186/cc9342
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. Methods: Twenty-one sheep (37 +/- 2 kg) were operatively prepared for chronic study and randomly allocated to either the sham, control, or rhAPC group (n = 7 each). The control and rhAPC groups were subjected to insufflation of four sets of 12 breaths of cotton smoke followed by instillation of live Pseudomonas aeruginosa into both lung lobes, according to an established protocol. Healthy sham animals were not subjected to the injury and received only four sets of 12 breaths of room air and instillation of the vehicle (normal saline). rhAPC (24 mu g/kg/hour) was intravenously administered from 1 hour post injury until the end of the 24-hour experiment. Regional microvascular blood flow was analyzed using colored microspheres. All sheep were mechanically ventilated with 100% oxygen, and fluid resuscitated with lactated Ringer's solution to maintain hematocrit at baseline levels. Results: The rhAPC-associated reduction in heart malondialdehyde (MDA) and heart 3-nitrotyrosine (a reliable indicator of tissue injury) levels occurred parallel to a significant increase in mean arterial pressure and to a significant reduction in heart rate and cardiac output compared with untreated controls that showed a typical hypotensive, hyperdynamic response to the injury (P < 0.05). In addition, rhAPC significantly attenuated the changes in microvascular blood flow to the trachea, kidney, and spleen compared with untreated controls (P < 0.05 each). Blood flow to the ileum and pancreas, however, remained similar between groups. The cerebral blood flow as measured in cerebral cortex, cerebellum, thalamus, pons, and hypothalamus, was significantly increased in untreated controls, due to a loss of cerebral autoregulation in septic shock. rhAPC stabilized cerebral blood flow at baseline levels, as in the sham group. Conclusions: We conclude that rhAPC stabilized cardiovascular functions and attenuated the changes in visceral and cerebral microcirculation in sheep suffering from ALI and septic shock by reduction of cardiac MDA and 3-nitrotyrosine.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock
    Marc O Maybauer
    Dirk M Maybauer
    John F Fraser
    Csaba Szabo
    Martin Westphal
    Levente Kiss
    Eszter M Horvath
    Yoshimitsu Nakano
    David N Herndon
    Lillian D Traber
    Daniel L Traber
    Critical Care, 14
  • [2] RECOMBINANT HUMAN ACTIVATED PROTEIN C IN SEPTIC SHOCK
    Garcia Olivares, P.
    Montero Roblas, J. I.
    Rodado Munoz, I.
    Arenal Lopez, S.
    Benitez Peyrat, J.
    Camino Redondo, N.
    Rodriguez Aguirregaviria, J.
    INTENSIVE CARE MEDICINE, 2009, 35 : 240 - 240
  • [3] Corticosteroids and Human Recombinant Activated Protein C for Septic Shock
    Colin, Gwenhael
    Annane, Djillali
    CLINICS IN CHEST MEDICINE, 2008, 29 (04) : 705 - +
  • [4] Nafamostat attenuates septic shock and acute lung injury in sheep
    Murakami, K
    McGuire, R
    Soejima, K
    Traber, LD
    Traber, DL
    ANESTHESIOLOGY, 2000, 93 (3A) : U157 - U157
  • [5] Effects of recombinant human activated protein C on coagulation in ovine septic shock following smoke inhalation injury
    Maybauer, M. O.
    Maybauer, D. M.
    Fraser, J. F.
    Traber, L. D.
    Enkhbaatar, P.
    Westphal, M.
    Murakami, K.
    Nakano, Y.
    Traber, D. L.
    INFECTION, 2005, 33 : 30 - 30
  • [6] Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep
    Waerhaug, Kristine
    Kuklin, Vladimir N.
    Kirov, Mikhail Y.
    Sovershaev, Mikhail A.
    Langbakk, Bodil
    Ingebretsen, Ole C.
    Ytrehus, Kirsti
    Bjertnaes, Lars J.
    CRITICAL CARE, 2008, 12 (04):
  • [7] Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep
    Kristine Waerhaug
    Vladimir N Kuklin
    Mikhail Y Kirov
    Mikhail A Sovershaev
    Bodil Langbakk
    Ole C Ingebretsen
    Kirsti Ytrehus
    Lars J Bjertnaes
    Critical Care, 12
  • [8] Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!
    Velik-Salchner, Corinna
    Wenzel, Volker
    Maybauer, Dirk M.
    Maybauer, Marc O.
    INTENSIVE CARE MEDICINE, 2007, 33 (12) : 2048 - 2050
  • [9] Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock
    Youcef Bouazza
    Nacira Sennoun
    Charlène Strub
    Véronique Regnault
    Sebastien Gibot
    Ferhat Meziani
    Patrick Lacolley
    Bruno Levy
    Intensive Care Medicine, 2011, 37 : 1857 - 1864
  • [10] Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?
    Maybauer, Marc O.
    Traber, Daniel L.
    Maybauer, Dirk M.
    CRITICAL CARE, 2009, 13 (01):